Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jan 17;16(1):675-85.
doi: 10.3390/molecules16010675.

The role of adenosine receptor agonists in regulation of hematopoiesis

Affiliations
Review

The role of adenosine receptor agonists in regulation of hematopoiesis

Michal Hofer et al. Molecules. .

Abstract

The review summarizes data evaluating the role of adenosine receptor signaling in murine hematopoietic functions. The studies carried out utilized either non-selective activation of adenosine receptors induced by elevation of extracellular adenosine or by administration of synthetic adenosine analogs having various proportions of selectivity for a particular receptor. Numerous studies have described stimulatory effects of non-selective activation of adenosine receptors, manifested as enhancement of proliferation of cells at various levels of the hematopoietic hierarchy. Subsequent experimental approaches, considering the hematopoiesis-modulating action of adenosine receptor agonists with a high level of selectivity to individual adenosine receptor subtypes, have revealed differential effects of various adenosine analogs. Whereas selective activation of A₁ receptors has resulted in suppression of proliferation of hematopoietic progenitor and precursor cells, that of A₃ receptors has led to stimulated cell proliferation in these cell compartments. Thus, A₁ and A₃ receptors have been found to play a homeostatic role in suppressed and regenerating hematopoiesis. Selective activation of adenosine A₃ receptors has been found to act curatively under conditions of drug- and radiation-induced myelosuppression. The findings in these and further research areas will be summarized and mechanisms of hematopoiesis-modulating action of adenosine receptor agonists will be discussed.

PubMed Disclaimer

References

    1. Drury A.N., Szent-Györgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J. Physiol. (London) 1929;68:213–237. - PMC - PubMed
    1. Abbracchio M.P. P1 and P2 receptors in cell growth and differentiation. Drug Dev. Res. 1996;39:393–406. doi: 10.1002/(SICI)1098-2299(199611/12)39:3/4<393::AID-DDR21>3.0.CO;2-1. - DOI
    1. Linden J. Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 2001;41:775–778. doi: 10.1146/annurev.pharmtox.41.1.775. - DOI - PubMed
    1. Berne R.M. Cardiac nucleotides in hypoxia – possible role in regulation of coronary blood flow. Am. J. Physiol. 1963;204:317–322. - PubMed
    1. Newby A.C. Adenosine and the concept of ‘retaliatory metabolites’. Trends Biochem. Sci. 1984;9:42–44. doi: 10.1016/0968-0004(84)90176-2. - DOI

Publication types

Substances

LinkOut - more resources